Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds-Reference-Cited by-同舟云学术

Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds

Published:2008-11 Issue:8 Volume:29 Page:455-468
ISSN:0142-2782
Container-title:Biopharmaceutics & Drug Disposition
language:en
Short-container-title:Biopharm. Drug Dispos.

Author:

Fura Aberra,Vyas Viral,Humphreys William,Chimalokonda Anjaneya,Rodrigues David

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,General Medicine

Reference36 articles.

1. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics;Feng;Pharm Res,2000

2. A novel strategy for physiologically based predictions of human pharmacokinetics;Jones;Clin Pharmacokinet,2006

3. Evaluation of human pharmacokinetics, therapeutic dose and exposure predictions using marketed oral drugs;McGinnity;Curr Drug Metab,2007

4. Prediction of human pharmacokinetics from hepatic microsomal intrinsic clearance and allometrically scaled preclinical data;Fura;Drug Metab Rev,2005

5. On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development;Lowe;Xenobiotica,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empirical scaling factor for predicting human pharmacokinetic profiles of disproportionate metabolites using the Css–MRTpo method and chimeric mice with humanised livers;Xenobiotica;2023-09-02

2. Practical Application of Pk/TK Models: Preclinical PK/TK and Clinical Trial;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

3. Shared learning from a physiologically based pharmacokinetic modeling strategy for human pharmacokinetics prediction through retrospective analysis of Genentech compounds;Biopharmaceutics & Drug Disposition;2023-05-09

4. Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis;Antimicrobial Agents and Chemotherapy;2021-07-16

5. A novel Css-MRTpo approach to simulate oral plasma concentration–time profiles of the partial glucokinase activator PF-04937319 and its disproportionate N-demethylated metabolite in humans using chimeric mice with humanized livers;Xenobiotica;2019-11-22